SEC Form 4/A · accession 0001179110-15-006136
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Tom Maniatis
Director
Period of report
Jan 8, 2015
Accepted (ET)
Apr 8, 2015 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $41.20 | Jan 8, 2015 | A | 10,000 | A | — | Jan 8, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares of common stock underlying this stock option award vest in full on the one year anniversary of the grant date. The vesting schedule for this stock option award included on the Form 4 filed on January 9, 2015 for this reporting person incorrectly stated that the shares of common stock underlying this stock option award vest in equal quarterly installments over the first three years after the grant.
Remarks
As noted in footnote 1, this Form 4/A amends the Form 4 filed on January 9, 2015 for this reporting person.